ARTICLE | Company News
Myriad Genetics, Novartis Pharmaceuticals Corp. deal
March 16, 1998 8:00 AM UTC
MYGN received a $500,000 milestone from partner Novartis for its discovery of CHD1, a gene associated with cardiovascular disease (see Technology Briefing, BioCentury Part I). ...